Brought to you by:
FDA announces plans to address medical device shortage risks
The Food and Drug Administration (FDA) has issued a statement outlining measures to enhance protections against medical device shortages. According to Michelle Tarver, director of the FDA’s Center for Devices and Radiological Health (CDRH), supply chain disruptions—often caused by natural…
SVS gets moving on PAD-related grant
All those steps logged during the SVS Foundation’s exercise challenge in September will help the Foundation—and researchers—take new steps to unlock new treatments for peripheral artery disease (PAD). The foundation’s Vascular Health Step Challenge, during National PAD Awareness Month, raised…
ESVS publishes 2025 vascular trauma guidelines
The European Society for Vascular Surgery (ESVS) has developed new guidelines for the care of patients with vascular trauma. The 2025 clinical practice guideline document was recently published as an open-access article in press in the European Journal of Vascular…
New data support role of F/BEVAR for treatment of thoracoabdominal aortic aneurysms
A recent prospective, multicentre cohort study provides insights into early and late aortic-related mortality and rupture after fenestrated and branched endovascular aneurysm repair (F/BEVAR) of thoracoabdominal aortic aneurysms (TAAAs). Researchers claim these are likely to represent the most comprehensive data…
Gore receives CE mark for lower profile Viabahn VBX endoprosthesis
Gore has announced recent CE mark of a lower profile Viabahn VBX balloon expandable endoprosthesis (VBX stent graft). Medical Device Regulation (MDR) approval of this innovation builds on a proven device which has become an important tool for treating complex…
One-year SAVVE trial results are ‘most encouraging data ever produced for a bioprosthetic vein valve’
The one-year data from the SAVVE trial represent the “most encouraging clinical data that have ever been produced for a bioprosthetic deep vein valve” in more than half a century of attempts at developing such a device, according to one…
Researchers develop machine learning models to predict IVC filter complications
Researchers in Canada have developed machine learning (ML) models that they claim, “can accurately predict one-year IVC [inferior vena cava] filter complications, performing better than logistic regression”. Writing in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL), Ben…
Boston Scientific to acquire IVL developer Bolt Medical
Boston Scientific has announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease. “Representing one of the fastest growing…
Large database study finds no difference in outcomes between three carotid shunting strategies
A new Vascular Quality Initiative (VQI) data analysis, recently published in the European Journal of Vascular and Endovascular Surgery (EJVES), has found no statistically significant differences between three carotid endarterectomy (CEA) shunting strategies regarding in-hospital stroke and death rate, including…
Study finds adverse outcomes after decreased use of paclitaxel-coated devices
A recent analysis of over 270,000 Medicare fee-for-service beneficiaries has found an increase in adverse outcomes and death after a US Food and Drug Administration (FDA) warning led to decreased use of paclitaxel-coated devices for peripheral revascularisation procedures. Writing in…